BioSpace News Archive

Business

Bio-Process Systems Alliance Elects Board Members for 2018-2019 Terms

The BPSA is pleased to announce the election of Board of Directors members who will serve two-year terms in leadership roles through December 31, 2019.

January 9, 2018
·
2 min read
Biotech Bay

Gynesonics Announces Results from Pivotal IDE Trial for Incision Free Treatment for Uterine Fibroids

The FDA specified co-primary endpoints were reduction of bleeding and freedom from surgical reintervention due to HMB, both at 12-month follow-up.

January 9, 2018
·
4 min read
Policy

Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn for Management of Blepharitis, Microsafe Oral Care for Mucositis and Sinudox for Chronic Sinusitis

The first approval is for Acuicyn eyelid and eyelash hygiene, an antimicrobial solution (hypochlorous acid) indicated to treat symptoms and causes of blepharitis on the eyelid and eyelash.

January 9, 2018
·
6 min read
Pharm Country

Creative Diagnostics Launches Epigenetics Antibodies for Bio-research Communities

Now highly specific antibodies are available at Creative Diagnostics to most histone modifications validated in CHIP.

January 9, 2018
·
2 min read
Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming

The first patient was enrolled by The Center for Interventional Pain & Spine in Wilmington, Delaware.

January 9, 2018
·
6 min read
BioMidwest

SCORR Marketing and Applied Clinical Trials Release Report on Clinical Research Industry Salary and Employee Satisfaction

SCORR Marketing, a global health science marketing and communications firm, has announced that a new Industry Salary and Employee Satisfaction Survey Report is now available for free download.

January 9, 2018
·
1 min read
Business

gel-e Expands Clinical Advisory Board With More Surgical Talent

gel-e announces the expansion of its Clinical Advisory Board to include Dr. Grant Bochicchio, Chief of Acute and Critical Care Surgery at Washington University School of Medicine.

January 9, 2018
·
2 min read
Drug Development

Axsome Tanks as Pain Syndrome Drug Flunks Phase III Study

The CREATE-1 trial was a randomized, double-blind, placebo-controlled Phase 3 trial in patients with CRPS.

January 9, 2018
·
10 min read
Drug Development

FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study

The Company’s PLX-PAD program has already been selected for accelerated approval pathways in both regions, including the FDA’s Fast Track Designation and the EMA Adaptive Pathways program.

January 9, 2018
·
5 min read
GN Store Nord: Transactions in Relation to Share Buyback Program – Jan. 9, 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 9, 2018
·
2 min read